リトアニアのバイオテクノロジー企業バイオテックファーマ(Biotechpharma)が米国のボストンに子会社を設立した。米国の顧客の近くで活動する目的で、投資額は約2,500万ユーロに上る。今年半ばに製法開発研究所を立ち上げ、来年末にも生産を開始する計画だ。
リトアニアのバイオテクノロジー企業バイオテックファーマ(Biotechpharma)が米国のボストンに子会社を設立した。米国の顧客の近くで活動する目的で、投資額は約2,500万ユーロに上る。今年半ばに製法開発研究所を立ち上げ、来年末にも生産を開始する計画だ。
Cookie | 期間 | 説明 |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |